Professor Azra Ghani is Director of the MRC Centre for Global Infectious Disease Analysis, Acting Head of the Department of Infectious Disease Epidemiology and a Professor in Infectious Disease Epidemiology at Imperial College London. She also holds a Visiting Professor appointment at the Lee Kong Chian School of Medicine at the Nanyang Technological University in Singapore.
She has worked on a wide range of infectious diseases, including BSE and vCJD, sexually transmitted infections, SARS, COVID-19, influenza and malaria. She is currently a member of the WHO Malaria Policy Advisory Group, the Gavi Vaccine Investment Strategy Steering Committee and the Coalition for Epidemic Preparedness (CEPI) Scientific Advisory Committee. She was previously a Trustee for the international charity Malaria No More UK and continues to support their work as a special advisor.
She was elected a Fellow of the Academy of Medical Sciences in 2017, awarded the Chalmers Medal by the Royal Society of Tropical Medicine and Hygiene in 2017, the Unilver Colworth Prize by the Microbiology Society in 2021 and appointed a Member of the British Order (MBE) in the 2021 Birthday Honours.
Professor Ghani teaches on Imperial College London's short course on Epidemiology and Control of Infectious Diseases. This is aimed at public health professionals, policy-makers and researchers who want to learn about the basic principles and practical applications of mathematical modelling and modern quantitative methods.
Short course on Epidemiology and Control of Infectious Diseases: www.infectiousdiseasemodels.org
et al., 2023, No evidence of sustained nonzoonotic <i>Plasmodium knowlesi</i> transmission in Malaysia from modelling malaria case data, Nature Communications, Vol:14
et al., 2022, Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study, The Lancet Global Health, Vol:10, ISSN:2214-109X, Pages:e1782-e1792
et al., 2022, Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:1293-1302
et al., 2020, The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries, Science, Vol:369, ISSN:0036-8075, Pages:413-422
et al., 2020, Estimates of the severity of coronavirus disease 2019: a model-based analysis., Lancet Infectious Diseases, Vol:20, ISSN:1473-3099, Pages:669-677
et al., 2016, Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study, Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:465-472
et al., 2015, Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:1450-1458
et al., 2010, Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies., Plos Med, Vol:7, ISSN:1549-1676, Pages:1-27
et al., 2020, Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand